Navigating Tax Developments and Opportunities for the Life Sciences Sector

The life sciences industry is a complex one that looks set to become more challenging, including its tax landscape.

Shifts in the supply chains, expiring patents and evolving legislation create pressure and ensuing tax and finance issues for the wider enterprise.

In this event, we will share trends and opportunities shaping the future of the life sciences sector and delve into the latest tax trends and implications for your business. Keep abreast of the latest corporate tax updates and how it may affect your tax planning and compliance strategies. Life sciences companies looking to make significant investments in Singapore may consider the Refundable Investment Credits (RIC) - a new Singapore incentive scheme - in their investment strategy together with other potential tax and non-tax incentives. We will also share how the latest e-invoicing developments could impact your invoicing processes.

This event is exclusively designed for senior tax and finance professionals in the life sciences sector. Join us for insightful discussions and networking opportunities with EY teams and industry peers.

Event agenda

• Life sciences sector trends and opportunities
• Corporate tax trends and developments
• How will the new RIC scheme fit into your overall incentive and investment strategy?
• E-invoicing developments and considerations

I'd Like to attend

Event Location